| Literature DB >> 29633257 |
André Dallmann1, Marc Pfister1,2, John van den Anker1,3,4, Thomas Eissing5.
Abstract
During recent years there has been a surge in developing and applying physiologically based pharmacokinetic (PBPK) models in pregnant women to better understand and predict changes in drug pharmacokinetics throughout pregnancy. As a consequence, the number of publications focusing on pregnancy PBPK models has increased substantially. However, to date these models, especially across various platforms, have not been systematically evaluated. Hence, this review aims to assess published PBPK models in pregnancy used for therapeutic purposes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29633257 DOI: 10.1002/cpt.1084
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875